Acute kidney injury
Acute kidney injury is a measurable fall in kidney filtration or urine output caused by reduced perfusion, intrinsic renal disease or obstruction; identify the cause early, protect the kidneys, monitor complications and escalate for refractory life-threatening physiology.
In a nutshell
AKI is a change in creatinine or urine output from baseline. Find the cause in parallel: perfusion/sepsis, medicines and toxins, intrinsic renal disease and obstruction. Protect the kidneys, monitor potassium and fluid status, and escalate urgently for refractory hyperkalaemia, acidosis, uraemic complications, fluid overload or pulmonary oedema.
Classic presentation
An acutely unwell patient has a rising creatinine or oliguria after vomiting, sepsis, hypotension, surgery, nephrotoxic medicines or possible obstruction, with or without hyperkalaemia or fluid overload.
Key points
- AKI criteria include a creatinine rise of at least 26 micromol/L within 48 hours, a 50% rise within 7 days or oliguria below 0.5 ml/kg/hour for more than 6 hours in adults.
- Check fluid status, sepsis, medication exposure, intrinsic renal features and obstruction at the same time; pre-renal and intrinsic causes can coexist.
- Perform urine dipstick for blood, protein, leucocytes, nitrites and glucose as soon as AKI is suspected.
- Do not routinely give loop diuretics to treat AKI and never use low-dose dopamine; consider a loop diuretic only for fluid overload or while awaiting RRT.
- Stage 3 AKI, unclear cause, inadequate response, complications, transplant or CKD stage 4/5 needs nephrology discussion within 24 hours.
- RRT indications are refractory hyperkalaemia, acidosis, uraemic complications, fluid overload or pulmonary oedema; do not use an isolated creatinine or potassium number.
- After AKI, monitor recovery and longer-term CKD risk; NICE recommends at least 3 years of CKD monitoring, longer after stage 3, even if eGFR recovers.
First-line investigation
Compare creatinine with baseline, measure urine output, assess fluid status and perform urine dipstick plus complication blood tests.
Management
Stabilise and monitor
Identify the mechanism
Protect renal function
Refer and consider RRT
Exam traps
- A normal-looking creatinine does not exclude AKI without a baseline comparison.
- Do not give repeated fluid boluses without reassessing for congestion or pulmonary oedema.
- Do not use eGFR to stage rapidly changing AKI as if it were stable CKD.
- Do not delay emergency contrast when the risk of delaying diagnosis or treatment is clinically significant.
- Do not routinely give furosemide to make urine or use low-dose dopamine as a renal-protective treatment.
- A patient with haematuria and proteinuria without UTI or catheter trauma may have nephritis and needs renal discussion.
- Do not wait for severe creatinine elevation before treating refractory potassium, acidosis, uraemia or pulmonary oedema.
Illustrations
Key sources
- NICE NG148: Acute kidney injury, recommendations (NG148, last updated 16 October 2024)
- UK Kidney Association: Acute kidney injury guideline (UKKA AKI guideline, published 2019 and reviewed 1 August 2024)
- BNF: Ibuprofen (BNF medicine monograph for NSAID renal cautions)
- BNF: Ramipril (BNF medicine monograph for ACE-inhibitor cautions and renal monitoring)
- BNF: Losartan (BNF medicine monograph for ARB cautions and renal monitoring)
- BNF: Furosemide (BNF medicine monograph for loop-diuretic use and monitoring)
- NICE NG203: Chronic kidney disease, recommendations (NG203 recommendations for monitoring after AKI)
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

